Aufa, Syafiq, and Jufriady Ismy. “Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer”. Indonesian Journal of Global Health Research 8, no. 6 (September 4, 2026): 89–98. Accessed September 4, 2026. https://jurnal2.globalhealthsciencegroup.com/index.php/IJGHR/article/view/2572.